Relationship between Markers of Gut Barrier Function and Erythrocyte Membrane PUFAs in Diarrhea-Predominant IBS Patients Undergoing a Low-FODMAP Diet
Authors:
- Michele LinsalataMLMichele Linsalata
- Antonia IgnazziAIAntonia Ignazzi
- Benedetta D’attomaBDBenedetta D’attoma
- Giuseppe RiezzoGRGiuseppe Riezzo
- Domenica MallardiDMDomenica Mallardi
- Antonella OrlandoAOAntonella Orlando
- Laura ProsperoLaura Prospero
- Maria NotarnicolaMNMaria Notarnicola
- Valentina De NunzioVNValentina De Nunzio
- Giuliano PintoGPGiuliano Pinto
- Francesco RussoFrancesco Russo
Open Access
Abstract
Many patients with irritable bowel syndrome (IBS) have a compromised intestinal barrier associated with low-grade inflammation. Polyunsaturated fatty acids (PUFAs) are potential mediators of inflammation: omega-6 PUFAs are pro-inflammatory, while omega-3 PUFAs are antioxidant and anti-inflammatory. Zonulin is a potential biomarker for small intestinal permeability (s-IP). This study investigated the relationship between PUFAs and gastrointestinal (GI) barrier integrity in IBS patients with predominant diarrhea (IBS-D). We evaluated GI barrier function indicators in the urine and bloodstream and erythrocyte membrane PUFA composition in 38 IBS-D patients (5 men, 33 women, 44.11 ± 1.64 years), categorized at baseline by fecal zonulin levels into high (≥107 ng/mL, H-FZ) and normal (n-3 PUFAs levels, and higher n-6/n-3 PUFAs and arachidonic acid (AA) to eicosapentaenoic acid (EPA) ratios than N-FZ. After LFD, H-FZ patients showed significant increases in n-3 PUFAs levels; decreases in n-6 PUFAs, n-6/n-3 PUFAs and AA/EPA ratios; and improved s-IP. The n-6/n-3 PUFAs ratio positively correlated with fecal zonulin levels in all subjects. These findings highlight the relationship between PUFAs and the intestinal barrier, suggesting their role in IBS-D pathophysiology and confirming the positive effects of LFD in managing IBS-D.Keywords
Funding Information
- Italian Ministry of Health RC 2020–2021, Prog. N_ 16 (DDG n. 700/2020)
This publication has 47 references indexed in Scilit:
- The low FODMAP diet in clinical practice: where are we and what are the long-term considerations?Proceedings of the Nutrition Society, 2023
- The early impact of diets enriched with saturated and unsaturated fatty acids on intestinal inflammation and tight junctionsThe Journal of Nutritional Biochemistry, 2023
- Omega-3 polyunsaturated fatty acids improve intestinal barrier integrity—albeit to a lesser degree than short-chain fatty acids: an exploratory analysis of the randomized controlled LIBRE trialEuropean Journal of Nutrition, 2023
- EPA and DHA inhibit endocytosis of claudin-4 and protect against deoxynivalenol-induced intestinal barrier dysfunction through PPARγ dependent and independent pathways in jejunal IPEC-J2 cellsFood Research International, 2022
- Crosstalk among intestinal barrier, gut microbiota and serum metabolome after a polyphenol-rich diet in older subjects with “leaky gut”: The MaPLE trialClinical Nutrition, 2021
- Mechanisms regulating intestinal barrier integrity and its pathological implicationsExperimental & Molecular Medicine, 2018
- Pathophysiology of irritable bowel syndromeThe Lancet Gastroenterology & Hepatology, 2016
- n-3 and n-6 polyunsaturated fatty acids differentially regulate adipose angiotensinogen and other inflammatory adipokines in part via NF-κB-dependent mechanismsThe Journal of Nutritional Biochemistry, 2012
- Intestinal permeability, leaky gut, and intestinal disordersCurrent Gastroenterology Reports, 1999
- The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progressAlimentary Pharmacology & Therapeutics, 1997